Article
Heather Baumhauer, MERIT's VP of Clinical Services, discusses project management's role at MERIT and describes her journey into the world of clinical research....
OPHTHALMOLOGY CASE STUDY
Complex Global Imaging Study in Pediatric Population
Anti-VEGF treatment via intravitreal injection has the potential to offer improved outcomes in the high-risk, vulnerable premature newborn population with ROP.
Complex Global Imaging Study in Pediatric Population
Anti-VEGF treatment via intravitreal injection has the potential to offer improved outcomes in the high-risk, vulnerable premature newborn population with ROP.
RESPIRATORY CASE STUDY
Centralized Spirometry Clinical Trial Endpoints
MERIT’s centralized spirometry services laid the foundation for this successful multi-study COPD development program.
Centralized Spirometry Clinical Trial Endpoints
MERIT's centralized spirometry services laid the foundation for this successful multi-study COPD development program.
ONCOLOGY SOLUTIONS
Collect and Hold Services
MERIT’s Collect and Hold services are ideal for early phase clinical trials in which there is a need to collect longitudinal imaging data, or where centralized imaging review may be incorporated at a later point in time.
Collect and Hold Services
MERIT’s Collect and Hold services are ideal for early phase clinical trials in which there is a need to collect longitudinal imaging data, or where centralized imaging review may be incorporated at a later point in time.
BCVA SOLUTIONS
BCVA Services
MERIT offers comprehensive training, certification, and management of study BCVA activities as well as centralized data review of BCVA source documents.
BCVA Services
MERIT offers comprehensive training, certification, and management of study BCVA activities as well as centralized data review of BCVA source documents.
ACCELERATE YOUR PRODUCT DEVELOPMENT WITH MERIT’S PROVEN EXPERTISE
We have substantial medical expertise in specialized therapeutic areas:
WHAT WE DO
MERIT is your clinical endpoint expert. We partner with CROs, pharmaceutical, and biotech companies to deliver reliable endpoint services in global clinical trials. Together our work advances and accelerates the improvement of therapeutic options for patients worldwide.
We standardize MERIT delivers standardized processes for site certification, data DICOMization, reader variability monitoring, and data output. This reduces data variability and risk by providing higher quality data.
We execute Our project management team provides personalized attention, collaborating closely with our partners to focus on details that drive study milestone achievement and increase site engagement.
We provide insight With decades of experience and deep knowledge in specific clinical domains, our team provides insight and actionable information in endpoint assessment. MERIT experts add value to your study by acting as an extension of your medical team.
We innovate MERIT's EXCELSIOR™ technology platform increases accuracy and efficiency by providing a suite of advanced endpoint analysis tools designed based on our extensive collaboration with biopharma companies.
STAY UPDATED
Stay up to date on the latest MERIT news and content.
Article
Julia Oxley, MERIT's Director of Business Development, discusses her team’s role at MERIT and her passion for clinical research....
Article
Article, Clinical Endpoint Experts / 09.08.2023
4 Reasons to Partner with a Respiratory Clinical Endpoint Expert
Discover 4 reasons to partner with a clinical endpoint expert for your next respiratory trial....
Article
Learn five facts about the current state of clinical trials including details about trial costs, enrollment issues, and the difficulty and complexity of today's studies....
Article
Article, Oncology / 21.06.2023
Treating Lung Cancer with Antibody-Drug Conjugates: Advancing Clinical Trials and New Updates at ASCO 2023
Given that the relative survival rate of patients diagnosed with metastatic lung cancer is low, and that traditional chemotherapy and surgery are of limited efficacy, ADCs represent a potentially important treatment option....
Uncategorized / 26.06.2023
Complex Global Imaging Study in Pediatric Population
Anti-VEGF treatment via intravitreal injection has the potential to offer improved outcomes in the high-risk, vulnerable premature newborn population with ROP. Learn more in our case study. ...
Learn how high-quality retinal images were key to this pilot study’s success and formed the basis for testing an AI algorithm....
Learn how MERIT’s imaging expertise and proprietary software play a vital role in gene therapy clinical trials. We leverage our experience supporting 29 gene therapy clinical trials, providing valuable knowledge of specialized modalities...
Ophthalmology / 07.11.2021
Complex Ophthalmic Imaging Solutions
MERIT’s Imaging Expertise and Proprietary Software Perform a Crucial Role in Global Phase III Wet AMD Study....
MERIT’s spirometry and MBPC expertise form the cornerstone for successful Phase III bioequivalence study for generic asthma treatment....
MERIT’s spirometry expertise and quality overreads lay the foundation for successful multi-study COPD drug development program....
MERIT at a Glance Solutions Guide
MERIT Ophthalmology Imaging Solutions Guide
MERIT Respiratory Solutions Guide
MERIT Oncology Imaging Solutions Guide
News Aug 15, 2023
News Jun 07, 2023
/ 07.06.2023
MERIT Achieves ISO 27001 Certification
News Feb 27, 2023
News Nov 15, 2022
/ 15.11.2022
FDA Expands 510(k) Clearance for MERIT’s Cloud-Based Imaging Management Platform, EXCELSIOR
MERIT's EXCELSIOR imaging software has received expansion of its FDA 510(k) market clearance (K#220929). The expanded clearance includes new indications for use such as interpretation and evaluation of radiologic images (CT, MR and PET) in clinical trials....
News Aug 16, 2022